Filed: 2/17/2026ACC: 0001013594-26-000252
📋 What this filing means
LION POINT CAPITAL, LP filed this quarterly 13F‑HR report disclosing 39 equity positions with a total reported market value of $19.32M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
39
Positions
$19.32M
Total AUM (reported)
5.63M
Total Shares
Allocation by class
COM$12.89M66.7%
COM NEW$3.70M19.1%
CLASS A ORD$889.6K4.6%
SHS CLASS A$826.9K4.3%
SPONSORED ADS$542.2K2.8%
SHS$351.8K1.8%
ORDINARY SHARES$129.5K0.7%
Portfolio Concentration
Top 3$3.73M19.3%
4–10$5.65M29.2%
11–25$6.97M36.1%
Rest$2.98M15.4%
Top 3 weight
19.3%
Top 10 weight
48.5%
Voting Authority Distribution
Total shares with voting rights: 5.63M
Sole
Full voting authority
5.63M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole39
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings39
Rows:
MILESTONE PHARMACEUTICALS IN
SOLEShares755K
TypeSH
Market value$1.53M
7.89%
Sole
755K
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares4.45K
TypeSH
Market value$1.31M
6.79%
Sole
4.45K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares67.50K
TypeSH
Market value$889.6K
4.60%
Sole
67.50K
Shared
0.00
None
0.00
FENNEC PHARMACEUTICALS INC
SOLEShares112.43K
TypeSH
Market value$865.7K
4.48%
Sole
112.43K
Shared
0.00
None
0.00
JASPER THERAPEUTICS INC
SOLEShares465K
TypeSH
Market value$851.0K
4.40%
Sole
465K
Shared
0.00
None
0.00
BENITEC BIOPHARMA INC
SOLEShares62K
TypeSH
Market value$835.1K
4.32%
Sole
62K
Shared
0.00
None
0.00
ROYALTY PHARMA PLC
SOLEShares21.40K
TypeSH
Market value$826.9K
4.28%
Sole
21.40K
Shared
0.00
None
0.00
GERON CORP
SOLEShares578K
TypeSH
Market value$763.0K
3.95%
Sole
578K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares36K
TypeSH
Market value$756.4K
3.91%
Sole
36K
Shared
0.00
None
0.00
ARDELYX INC
SOLEShares128.65K
TypeSH
Market value$750.0K
3.88%
Sole
128.65K
Shared
0.00
None
0.00
CUE BIOPHARMA INC
SOLEShares2.20M
TypeSH
Market value$672.8K
3.48%
Sole
2.20M
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares8.10K
TypeSH
Market value$643.2K
3.33%
Sole
8.10K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares28.50K
TypeSH
Market value$613.3K
3.17%
Sole
28.50K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares51.70K
TypeSH
Market value$583.7K
3.02%
Sole
51.70K
Shared
0.00
None
0.00
HUMACYTE INC
SOLEShares500K
TypeSH
Market value$480.3K
2.49%
Sole
500K
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares46K
TypeSH
Market value$477.9K
2.47%
Sole
46K
Shared
0.00
None
0.00
SERES THERAPEUTICS INC
SOLEShares31.57K
TypeSH
Market value$469.8K
2.43%
Sole
31.57K
Shared
0.00
None
0.00
COMPASS PATHWAYS PLC
SOLEShares58K
TypeSH
Market value$400.2K
2.07%
Sole
58K
Shared
0.00
None
0.00
DAY ONE BIOPHARMACEUTICALS I
SOLEShares42K
TypeSH
Market value$391.4K
2.03%
Sole
42K
Shared
0.00
None
0.00
REGENXBIO INC
SOLEShares26.60K
TypeSH
Market value$383.0K
1.98%
Sole
26.60K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares5K
TypeSH
Market value$382.4K
1.98%
Sole
5K
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares10.50K
TypeSH
Market value$381.0K
1.97%
Sole
10.50K
Shared
0.00
None
0.00
VENTYX BIOSCIENCES INC
SOLEShares41.50K
TypeSH
Market value$374.7K
1.94%
Sole
41.50K
Shared
0.00
None
0.00
LANTHEUS HLDGS INC
SOLEShares5.50K
TypeSH
Market value$366.0K
1.89%
Sole
5.50K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares18K
TypeSH
Market value$352.1K
1.82%
Sole
18K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MILESTONE PHARMACEUTICALS INSOLE | COM | 755K | SH | $1.53M 7.89% | 755K | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 4.45K | SH | $1.31M 6.79% | 4.45K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 67.50K | SH | $889.6K 4.60% | 67.50K | 0.00 | 0.00 |
FENNEC PHARMACEUTICALS INCSOLE | COM | 112.43K | SH | $865.7K 4.48% | 112.43K | 0.00 | 0.00 |
JASPER THERAPEUTICS INCSOLE | COM NEW | 465K | SH | $851.0K 4.40% | 465K | 0.00 | 0.00 |
BENITEC BIOPHARMA INCSOLE | COM NEW | 62K | SH | $835.1K 4.32% | 62K | 0.00 | 0.00 |
ROYALTY PHARMA PLCSOLE | SHS CLASS A | 21.40K | SH | $826.9K 4.28% | 21.40K | 0.00 | 0.00 |
GERON CORPSOLE | COM | 578K | SH | $763.0K 3.95% | 578K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 36K | SH | $756.4K 3.91% | 36K | 0.00 | 0.00 |
ARDELYX INCSOLE | COM | 128.65K | SH | $750.0K 3.88% | 128.65K | 0.00 | 0.00 |
CUE BIOPHARMA INCSOLE | COM | 2.20M | SH | $672.8K 3.48% | 2.20M | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 8.10K | SH | $643.2K 3.33% | 8.10K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 28.50K | SH | $613.3K 3.17% | 28.50K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 51.70K | SH | $583.7K 3.02% | 51.70K | 0.00 | 0.00 |
HUMACYTE INCSOLE | COM | 500K | SH | $480.3K 2.49% | 500K | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 46K | SH | $477.9K 2.47% | 46K | 0.00 | 0.00 |
SERES THERAPEUTICS INCSOLE | COM NEW | 31.57K | SH | $469.8K 2.43% | 31.57K | 0.00 | 0.00 |
COMPASS PATHWAYS PLCSOLE | SPONSORED ADS | 58K | SH | $400.2K 2.07% | 58K | 0.00 | 0.00 |
DAY ONE BIOPHARMACEUTICALS ISOLE | COM | 42K | SH | $391.4K 2.03% | 42K | 0.00 | 0.00 |
REGENXBIO INCSOLE | COM | 26.60K | SH | $383.0K 1.98% | 26.60K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 5K | SH | $382.4K 1.98% | 5K | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 10.50K | SH | $381.0K 1.97% | 10.50K | 0.00 | 0.00 |
VENTYX BIOSCIENCES INCSOLE | COM | 41.50K | SH | $374.7K 1.94% | 41.50K | 0.00 | 0.00 |
LANTHEUS HLDGS INCSOLE | COM | 5.50K | SH | $366.0K 1.89% | 5.50K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 18K | SH | $352.1K 1.82% | 18K | 0.00 | 0.00 |
Page 1 of 2